Pharmint

We are upgrading our infrastructure for a faster experience. We appreciate your patience in the meantime.

Liquimax SGPT (ALT)

Contact Seller for Price

Shipping is chargable

INTENDED USE: In vitro test for the quantitative determination of Alanine Aminotransferase (ALT) in human
serum and plasma.
P R O D U C T F E A T U R E S :
1. Two Liquid Reagents (4 parts of R1 + 1 part of R2).
2. Working reagent stability of 60 days at 2-8° C.
3. Linearity 500 IU/L.
4. Kinetic reaction time 4 minutes.
5. Kinetic factor 1746 at 340 nm at 37° C.
6. Measuring wavelength 340 nm.
7. Tailor made for tropical Conditions.
8. Incorporates Six Sigma methodologies throughout the manufacturing processes where in the
product under goes various stringent process checks like Defining, Measuring, Analyzing,
Improving and Controlling. (DMAIC)
9. No interference was observed by ascorbic acid up to 32 mg/dl, bilirubin up to 43 mg/dl,
haemoglobin up to 500 mg/dl and lipemia up to 2200 mg/dl.
10 Can be used on any discrete semi-automated and automated analyzers.
11. User friendly pack sizes (5 x 10ml, 4 x 25ml,10 x 25ml, 20 x 25ml).
an be used on any discrete semi automated and automated analyzer

Free shipping on orders over $10000!

  • No-Risk Money Back Guarantee!
  • No Hassle Refunds
  • Secure Payments

Request a Quote
Guaranteed Safe Checkout

Description

Alanine aminotransferase (glutamate-pyruvate-transaminase) belongs to the group of transaminases which catalyze the conversion of amino acids to the corresponding á-keto acids via the transfer of amino groups; they also catalyze the reverse process. Although higher activities exist in the liver, minor activity can also be detected in the kidneys, heart, skeletal muscle, pancreas, spleen, and lungs. Elevated levels of transaminases are indicative of myocardial infarction, hepatopathies, muscular dystrophy, and damage to internal organs. Increased ALT activity in the serum, however, is a rather specific indicator of damage to the liver parenchyma, while AST is not necessarily a liver-specific parameter. In 1956, Wroblewski and LaDue described the first kinetic determination of ALT in serum. In 1977 and 1980, the International Federation of Clinical Chemistry (IFCC) recommended standardized methods for the determination of ALT with optimized substrate concentrations. The method described here is derived from the IFCC reference method. *TRIS = Tris(hydroxymethyl)-aminomethane

Vendor Info

Vendor Information

  • Store Name: Avecon Healthcare
  • Vendor: Avecon Healthcare
  • No ratings found yet!

More Products

Product Enquiry

Product Enquiry

Your personal data will be used to support your experience throughout this website, to manage access to your account, and for other purposes described in our privacy policy

Scroll to Top

Please Provide name and email of your choice to start chat.